Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

15
Number of overlapping holdings
25.0%
% of XLV's 60 holdings also in AGNG
18.5%
% of AGNG's 81 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus AGNG)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in AGNG |
Overlap | |
---|---|---|---|---|
ABBVIE INC | 6.9% | 3.4% | 3.4% | |
AMGEN INC | 3.1% | 3.2% | 3.1% | |
JOHNSON & JOHNSON | 7.5% | 3.1% | 3.1% | |
ELI LILLY & CO | 12.3% | 3.1% | 3.1% | |
BOSTON SCIENTIFIC CORP | 2.8% | 4.1% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to AGNG
ELI LILLY & CO | 9.2% | |
UNITEDHEALTH GROUP INC | 9.0% | |
JOHNSON & JOHNSON | 4.4% | |
ABBOTT LABORATORIES | 4.3% | |
MERCK & CO. INC. | 4.3% | |
THERMO FISHER SCIENTIFIC INC | 3.6% | |
ABBVIE INC | 3.4% | |
INTUITIVE SURGICAL INC | 3.3% | |
PFIZER INC | 2.7% | |
GILEAD SCIENCES INC | 2.6% |
XLV Underweight Relative to AGNG
WELLTOWER, INC. | -4.8% | |
CHUGAI PHARMACEUTICAL CO LTD | -3.9% | |
ALCON, INC. | -3.3% | |
ROCHE HOLDING AG-BR | -3.2% | |
ASTRAZENECA PLC-SPONS ADR | -3.0% | |
UCB SA | -3.0% | |
TERUMO CORP | -2.4% | |
CELLTRION INC | -2.3% | |
VENTAS INC | -2.3% | |
BEIGENE LTD. SPONSORED ADR | -2.2% |